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One of the functions of sleep is to maintain energy balance in the brain.There are a variety
of hypotheses related to how metabolic pathways interact with sleep/wake regulation. A
major ﬁnding that demonstrates an interaction between sleep and metabolic homeostasis
is the involvement of adenosine in sleep homeostasis. An accumulation of adenosine is
supplied from ATP, which can act as an energy currency in the cell. Extracellularly, ATP
can act as an activity-dependent signaling molecule, especially in regard to communication
between neurons and glia, including astrocytes. Furthermore, the intracellular AMP/ATP
ratio controls the activity of AMP-activated protein kinase, which is a potent energy regu-
lator and is recently reported to play a role in the regulation of sleep homeostasis. Brain
ATP may support multiple functions in the regulation of the sleep/wake cycle and sleep
homeostasis.
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INTRODUCTION: ATP AS A NEUROMODULATOR
Sleep is thought to be essential to replenish energy sources in the
brain that are depleted during wakefulness. ATP has long been rec-
ognized as an intracellular energy source in the brain and multiple
other tissues, and the complex regulation of mitochondrial ATP
synthesis is triggered within the human brain in response to daily
activities (Kagawa, 2010). ATP has also been proposed as a puta-
tive transmitter in sensory nerves, motor nerves, and some CNS
neurons (Burnstock, 2007, 2009). In the CNS, ATP signaling can
regulate both excitatory and inhibitory neurotransmission. Many
neurons can releaseATP in an activity-dependentmanner, and this
molecule can act as a potent neuromodulator for neuron–neuron
and neuron–glial signaling (Fields and Stevens, 2000; Fields and
Burnstock, 2006; Krueger et al., 2008). ATP and its metabolites
regulate multiple processes in the nervous system including sleep
regulation (Burnstock et al., 2011).
Recently, it was observed in rats that ATP levels in several brain
regions (frontal cortex, basal forebrain, cingulate cortex, and hip-
pocampus) are stable during waking but exhibit a surge during the
initial hours of sleep (Dworak et al., 2010). This ATP surge dis-
plays a signiﬁcant positive correlation with the intensity of EEG
slow wave activity (SWA; 0.5–4Hz) in non-rapid eye movement
(NREM) sleep, a parameter of sleep depth and homeostatic need
for sleep. These results suggest that ATP levels drastically change
during sleep in several brain regions and are directly related to
SWA in NREM sleep (Dworak et al., 2010). Interestingly, sleep
deprivation for 3 h induces a signiﬁcant reduction in ATP con-
centration in the frontal cortex and lateral hypothalamus (an area
known to predominantly contain wake- and REM-active neurons)
although sleep deprivation does not affect the VLPO, an area
known to predominantly contain sleep-active neurons (Dworak
et al., 2010). Thus, elevations in brain ATP consumption caused
by prolonged wakefulness may differ depending on the brain
region.
The purpose of this review is to provide an overview of the
neurobiological evidence for the role of ATP in sleep regulation.
In this review, we will ﬁrst provide the experimental evidence for
an association between adenosine (a product from AMP) and
sleep regulation. A presentation of the evidence demonstrating
the role of gliotransmission in sleep homeostasis as mediated
by astrocytes will follow. Finally, we will address the possibility
of an involvement of AMP-activated protein kinase (AMPK), a
metabolic sensor, in sleep homeostasis.
ADENOSINE AND SLEEP
The hypnogenic properties of adenosine in speciﬁc brain areas
have been demonstrated in many studies. Infusion of adeno-
sine and adenosine transport inhibitors into the basal forebrain
increases sleep in cats and rats (Portas et al., 1997; Methippara
et al., 2005). Extracellular adenosine levels in the basal forebrain
measured bymicrodialysis are lower duringNREMandREMsleep
in cats,while levels are increased during sleep deprivation and sub-
sequently normalized during recovery sleep (Porkka-Heiskanen
et al., 2000). Furthermore, SWA in NREM sleep displays a strong
positive correlation with increases in adenosine levels in the basal
forebrain and frontal cortex during the recovery period after sleep
deprivation (Kalinchuk et al., 2011). These ﬁndings suggest that
adenosine is a sleep-promoting substance, decreasing the activ-
ity of cholinergic wake-promoting neurons in the basal forebrain
that are presumably responsible for the accumulation of adeno-
sine during prolonged waking (Porkka-Heiskanen and Kalinchuk,
2011).
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FIGURE 1 | Schematic of the intra- and extra-cellular
ATP/adenosine signaling cascades. Intracellularly, adenosine
is formed from AMP by cytosolic 5′-nucleotidase. Adenosine
kinase and adenosine deaminase convert adenosine to AMP
and inosine, respectively. Extracellularly, ATP, ADP, and AMP are
converted to adenosine by ecto-5′-nucleotidases. Intracellular and
extracellular adenosine levels are regulated by bi-directional equilibrative
nucleoside transporters.
An increase in adenosine levels reﬂects an increased breakdown
of cellular ATP (Figure 1). Intracellularly, ATP is metabolized to
ADP and then subsequently metabolized to AMP. AMP is further
metabolized to adenosine by cytosolic 5′-nucleotidase. Adenosine
can be converted back to AMP by adenosine kinase or converted
to inosine by adenosine deaminase. In terms of energy state mod-
ulation, adenosine kinase and adenosine deaminase are impor-
tant regulators of intracellular and extracellular adenosine levels.
Extracellularly, ATP, ADP, and AMP are converted to adenosine
by ecto-5′-nucleotidases. Adenosine concentration between the
intra- and extra-cellular spaces is equilibrated by nucleoside trans-
porters. When ATP is broken down in the cell, excess adenosine is
transported to the extracellular space by these transporters.
The adenosinergic regulation of sleep is predominantly medi-
ated either via A1 receptors (A1Rs) or A2a receptors (A2aRs).
The effects of adenosine in the basal forebrain on recovery sleep
mentioned above are mostly mediated by A1Rs. Perfusion of an
A1R antagonist into the basal forebrain reduces recovery sleep
after sleep deprivation, while an A2aR antagonist had no effect
on recovery sleep in rats (Gass et al., 2009). However, evidence
for a role of A2aRs in the regulation of sleep has also emerged,
especially concerning the actions of A2aRs in the leptomeninges
under the basal forebrain that are mediated by prostaglandin D2
and DP1 receptors (Urade and Hayaishi, 2011). In addition, it was
reported that administration of caffeine, a non-selective adeno-
sine receptor antagonist, induces arousal effects in wild-type and
A1R-knockout mice, although its effect was not observed in A2aR-
knockout mice, indicating that the arousal effects of caffeine are
dependent on A2aRs (Huang et al., 2005). Thus, adenosine regu-
lates either the amount of sleep or sleep homeostasis in multiple
ways depending on the brain area and receptor subtype.
GLIA AND SLEEP
Glia release multiple neuroactive substances that contribute to
sleep regulation including ATP, cytokines, and glutamate (Fields
and Burnstock, 2006; Krueger et al., 2008). Glia were thought to
play a passive and auxiliary role in the brain. However, in the
past decade, it has been reported that glia play more active roles
in the brain via neuron–astrocyte interactions. Astrocytes can be
activated by neurotransmitters released from active neurons they
surround. In turn, astrocytes release chemical transmitters to act
on neurons pre- and post-synaptically. This process of gliotrans-
mission modulates synaptic activity, with the primary chemicals
released from astrocytes being ATP, glutamate, and d-serine, all
of which can act to facilitate neural transmission (Hamilton and
Attwell, 2010).
Some recent studies have presented evidence that sleep home-
ostasis depends on gliotransmission and the accumulation of
adenosine degraded from ATP. These studies use transgenic mice
that express a dominant-negative (dn) SNARE domain selec-
tively in astrocytes, and such mice have impaired gliotransmission
(Halassa and Haydon, 2010; Florian et al., 2011). In the dnSNARE
mice, SWA in NREM sleep at baseline and during recovery peri-
ods after sleep deprivation is attenuated compared with that
observed in wild-type mice (Halassa et al., 2009). During sleep
deprivation, glutamate released from presynaptic neurons binds
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to postsynaptic AMPA receptors to facilitate excitatory neuro-
transmission (Figure 2). Glutamate also binds to metabotropic
glutamate receptors on the membranes of adjacent astrocytes and
can evoke rises in intracellularCa2+ concentration in astrocytes. In
turn, astrocytes release ATP when intracellular Ca2+ is elevated.
ATP released from activated astrocytes is rapidly hydrolyzed to
adenosine, which reduces the release of glutamate from the presy-
naptic terminal by acting on A1 receptors, ultimately resulting in
hyperpolarization of the postsynaptic neuron membrane poten-
tial (Jones, 2009). The dnSNARE mice, which have an impair-
ment of gliotransmission, display an impaired regulation of sleep
homeostasis, suggesting that gliotransmission is essential for sleep
pressure accumulation.
It is also well known that sleep loss can induce a deﬁcit in mem-
ory task performance in humans and rodents. The dnSNARE mice
were also protected against the effects of sleep deprivation in both
non-hippocampal- and hippocampal-dependent memory tasks
(Halassa et al., 2009; Florian et al., 2011). In addition, i.c.v. injec-
tion of the A1R antagonist 8-cyclopentyl-1,3-dimethylzanthine
(CPT) into wild-type mice mimicked the phenotype of dnSNARE
mice, suggesting that sleep homeostasis and cognitive deﬁcits are
due to adenosine actions via A1Rs. Thus, astrocytes regulate sleep
pressure, recovery, and associated cognitive consequences medi-
ated by adenosine in terms of dampening neuronal excitability.
Interestingly, extracellular ATP also activates purine P2 receptors
(e.g. P2X7) on glial cells to release cytokines such as interleukin-
1ß and tumour-necrosis factor-α, which act as sleep regulatory
substances (Krueger et al., 2008, 2010). Mice lacking functional
P2X7 receptors have attenuated NREM sleep and SWA in NREM
sleep during recovery periods after sleep deprivation compared
with wild-type mice (Krueger et al., 2010). These data sug-
gest that extracellular ATP and P2 receptors have an important
FIGURE 2 | Schematic of gliotransmission via astrocytic processes.
Glutamate released from presynaptic neurons binds to postsynaptic AMPA
receptors (AMPAR) and also to metabotropic glutamate receptors on
astrocytes. This stimulates an increase in intracellular Ca2+ concentration in
astrocytes, which in turn release ATP. Accumulation of adenosine from ATP
breakdown in the extracellular space acts via adenosine 1 receptors (A1Rs)
to depress synaptic activity.
role in the regulation of sleep homeostasis and link neuro- and
gliotransmission to sleep.
AMPK AND SLEEP
AMP-activated protein kinase is an efﬁcient sensor of the cellular
energy state, and regulates energy balance in the hypothalamus,
liver, muscle, adipose tissue, and pancreas (Kahn et al., 2005;
Minokoshi et al., 2008). AMPK is activated by phosphorylation
when the intracellular AMP/ATP ratio increases, an indication
that cellular energy consumed exceeds energy produced. In order
to restore energy balance, activated AMPK upregulates catabolic
pathways generating ATP such as fatty acid oxidation and glucose
uptake, while it downregulates anabolic pathways consuming ATP
such as lipid and carbohydrate synthesis. Therefore, dysfunction
of peripheral AMPK leads to metabolic syndromes including type
2 diabetes and obesity (Hardie, 2008; Zhang et al., 2009).
Pharmacological experiments have indicated that energy deple-
tion using 2,4-dinitrophenol (DNP), which blocks ATP synthesis
and increases the AMP/ATP ratio, increases the amount of NREM
sleep and also enhances SWA in NREM sleep (Kalinchuk et al.,
2003). In agreement with this study, we have recently demon-
strated that i.c.v. injection of 5-aminoimidazole-4-carboxamide
riboside (AICAR), an AMP-mimicking activator of AMPK,
enhances SWA in NREM sleep, while i.c.v. injection of compound
C (CC), an AMPK inhibitor, suppresses SWA compared to vehicle
injection in mice (Chikahisa et al., 2009). Furthermore, we have
demonstrated that 6 h of sleep deprivation increases AMPK activ-
ity in the hypothalamus of mice (Chikahisa et al., 2009). This sleep
deprivation-induced activation of AMPK is also observed in the
basal forebrain, and is accompanied by decreased ATP levels in
FIGURE 3 | Proposed model of increased AMPK activity during
prolonged wakefulness. Prolonged wakefulness such as sleep deprivation
activates central AMPK via decreased AMP/ATP ratio or increased CaMkk2
expression. An activation of AMPK enhances energy-producing catabolic
pathways and attenuates energy-consuming anabolic pathways.
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the same brain regions (Dworak et al., 2010). We also observed
that mRNA levels of Ca2+/calmodulin (CaM)-dependent pro-
tein kinase kinase β (CaMKK2), an additional upstream kinase
of AMPK, were increased immediately after 6 h of sleep depriva-
tion and that carnitine palmitoyltransferase 1 (CPT1), a signaling
factor downstream of AMPK, was increased during the recovery
period after sleep deprivation (Chikahisa et al., 2009). These ﬁnd-
ings suggest that prolonged wakefulness enhances the activity of
centralAMPKby increases in theAMP/ATP ratio and/or CaMKK2
expression. Subsequent activation of central AMPK would then
cause an enhancement of SWA in NREM sleep (Figure 3).
AMP-activated protein kinase is also known to be involved in
circadian rhythms, and directly regulates phosphorylation and
degradation of cryptochrome 1 (CRY1), a circadian clock com-
ponent (Lamia et al., 2009). Furthermore, mice with a genetic
disruption of the AMPK pathway show an attenuation of circa-
dian rhythms in the expression of several clock genes in the liver
(Lamia et al., 2009). Taken together, AMPK plays an important
role in linking energy metabolism and the regulation of circadian
and sleep homeostasis. Of course, ATP is itself affected by circa-
dian cycles. The ATPase activity of KaiC constitutes the circadian
system of cyanobacteria (Terauchi et al., 2007), while ATP release
in astrocytes is also regulated by circadianmechanisms (Marpegan
et al., 2011). Circadian clock components and ATP modulation of
mammalian CNS activity may cross-communicate and constitute
a dual mechanism driving the regulation of AMPK as a sensor of
cellular energy states.
FUTURE DIRECTIONS
Due to several advanced studies, an involvement of ATP as
an energy source or as a neuromodulator in the regulation
of sleep has been identiﬁed in the past few years. We now
have a better understanding of the functional properties of ATP
as a result of individual investigations into the properties of
astrocytic, adenosine, and AMPK signaling. However, several
questions still remain unanswered. SWA in NREM sleep was
recently discovered to be controlled locally in the cortex (Vya-
zovskiy et al., 2011). Does ATP or its metabolites play a potent
physiological role in sleep regulation in the cortex? Does ATP
have a role in the connection between hypothalamic and cor-
tical signaling? Further critical research to help understand the
pathophysiological mechanisms of sleep disorders and the inter-
action between sleep impairment and metabolic syndrome is
anticipated.
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